Pantoprazole Mylan (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazole Mylan, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis and Zollinger‑Ellison syndrome in adult patients. GNH USA supplies Pantoprazole Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole Mylan is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and acid reflux symptoms. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - NSAID‑induced gastric ulcer prevention: reduces risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance when used with antibiotics.

Pantoprazole is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring intermittently. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort or cramping. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests.

Before initiating therapy with Pantoprazole, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Review hepatic status: monitor in patients with liver disease. - Evaluate for osteoporosis risk: long‑term therapy may affect bone density. - Monitor magnesium levels: especially in patients on diuretics or prolonged treatment. - Consider pregnancy status: use only if benefits outweigh risks. - Store at room temperature: keep in the original container, protect from moisture and heat.

Pantoprazole may interact with other medicines, altering their effectiveness or safety.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption. - HIV protease inhibitors (e.g., atazanavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Methotrexate (high dose): possible increased toxicity. - Digoxin: altered serum levels, observe for signs of toxicity.